It's amusing how the article compares Theranos to Moderna (who are working on a new class of RNA therapies), and then states that "focus" is the main difference. Nevermind the fact that Moderna is trying to solve a real problem (make new cures for rare diseases), while Theranos is trying (and failing) to build a product that only solves the problem of the founder's bloodtest phobia.